IP Library Granted Patent US 8,705,029
Granted Patent B2
US 8,705,029 · App. 13/739,607 · Granted Apr 22, 2014

System and method for detection of analytes in exhaled breath

Inventors: Göran Palmskog (Järfälla, SE); Olof Beck (Saltsjöö-Boo, SE); Per Ola Andersson (Umeå, SE)
Assignee: Sensa Bues AB
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,705,029
App. No.
13/739,607
Granted
Apr 22, 2014
Kind
B2
Abstract

A device, system, and methods are disclosed for detecting the presence or determining a quantitative amount of at least one drug substance from exhaled breath of a subject in-situ. A collecting surface has a Surface Enhanced Raman Spectroscopy (SERS)-active layer that comprises at least one SERS-active material. The collecting surface is arranged as an outer surface of a waveguide for contact with exhaled breath, such that at least traces of said at least one drug substance in said exhaled breath can contact said SERS-active layer for read-out of a Raman shift spectrum that is detected in-situ for said detecting the presence or determining the quantitative amount of said at least one drug substance from said exhaled breath.

Claims (29)

1. A method of recovering exhaled nonvolatile drug compounds from a filter, comprising:

providing said filter comprising an exhaled aerosol comprising said nonvolatile drug compounds;

eluting said nonvolatile compounds from said filter with an organic solvent to form a sample;

evaporating at least a portion of said sample on a SERS-active surface;

recording at least one SERS-spectrum of said evaporated portion of said sample using SERS-technique.

2. The method according to claim 1 , performing an analysis of the content in said sample from said at least one recorded SERS-spectrum.

3. The method according to claim 1 , comprising identifying said nonvolatile drug compounds from said SERS-spectra using a multivariate data model.

4. The method according to claim 2 , performing an analysis of the content in said sample from said at least one recorded SERS-spectrum.

5. The method according to claim 1 , comprising facilitating analysis by modifying said SERS-active surface to be selective towards certain drug compounds.

6. The method according to claim 5 , comprising mixing a polymeric layer with nanoparticles to obtain a SERS-active surface.

7. The method according to claim 5 , wherein said SERS-active surface is possessing suitable physiochemical properties for diffusion certain class of drug compounds.

8. The method according to claim 5 , comprising adding a permeable layer selected from a group comprising silicone polymers, silica or silicone-elastomers to said SERS-active surface.

9. The method according to claim 8 , wherein said added layer is covering, coating or encapsulating said SERS-active surface.

10. The method according to claim 6 , comprising adding a permeable layer selected from a group comprising silicone polymers, silica or silicone-elastomers to said SERS-active surface.

11. The method according to claim 5 , comprising mixing of at least one SERS-active material and at least one material selected from a group comprising silicone elastomers, silicone polymers or silica to form said SERS-active surface.

12. The method according to claim 6 , comprising mixing of at least one SERS-active material and at least one material selected from a group comprising silicone elastomers, silicone polymers or silica to form said SERS-active surface.

13. The method according to claim 1 , comprising adding pure deionized water to the sample.

14. The method according to claim 1 , wherein detectable nonvolatile drug compounds is included in the list comprising: Amphetamines, ecstasy, Cannabis (THC and cannabinoids), Opiates heroin/morphine, 6-AM), Cocaine, Benzodiazepines, Propoxyphene, Methadone, Buprenorphine, Tramadol, LSD, Designer/Internet drugs, Kathinon, GHB, Meprobamat, Z-drugs, Tryptamines and Anabolic steroids.

15. A non-transitory computer-readable medium comprising a computer program configured for said recording at least one SERS-spectrum according to claim 1 and said performing an analysis according to claim 2 , wherein said computer program comprises code segments for:

recording at least one SERS-spectrum according to claim 1 ;

analyzing said at least one SERS spectrum according to claim 2 ; and

reporting a presence or determining a quantitative amount of nonvolatile drug compounds, in said exhaled breath sample.

16. The non-transitory computer-readable medium of claim 15 , further comprising a code segment for identifying said nonvolatile drug compounds from said at least one SERS-spectrum using a multivariate data model.

17. A method of detecting a nonvolatile drug compound present in exhaled breath, the exhaled breath being absorbed on a filter, the method comprising:

eluting said nonvolatile drug compound from said filter with an organic solvent to form a sample;

evaporating at least a portion of said sample on a SERS-active surface;

recording at least one SERS-spectrum of said evaporated portion of said sample using SERS-technique.

18. The method of according to claim 17 , further comprising capturing an exhaled aerosol from the exhaled breath in said filter.

19. The method according to claim 18 , further comprising a subject exhaling into said filter.

Assignments (2)
SECURITY INTEREST Recorded Oct 12, 2020
From: SENSA BUES AB
To: KIPA AB
Reel/Frame 054235/0411 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2013
From: PALMSKOG, GORAN; BECK, OLOF; ANDERSSON, PER OLA
To: SENSA BUES AB
Reel/Frame 029615/0120 →
Continuity (3)
Continuation 13394979
Provisional Application 61240752 · Sep 9, 2009
Related Publication 20130128260A1 · May 23, 2013